Medtronic's $43B Covidien deal: More to come? By: CNBC.com News June 16, 2014 at 09:26 AM EDT Medtronic's $43 billion Covidien deal, which boosts its negotiating power for the Affordable Care Act, may be a sign of future medical-device mergers. Read More >> Related Stocks: Abbott Laboratories Becton Dickinson Eli Lilly Gsk Plc ADR Johnson & Johnson Novartis Ag ADR Smith & Nephew Snats ADR St. Jude Medical Stryker Corp Wells Fargo Zimmer Holdings